Back
Federal Realty Investment Trust Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
55
FRT
Federal Realty Investment Trust
Last Price:
100.85
Seasonality Move:
1.61%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Buy
55
Federal Realty Investment Trust (FRT)
is a Buy
Is Federal Realty Investment Trust a Buy, Sell or Hold?
- The current Federal Realty Investment Trust [FRT] share price is $100.97. The Score for FRT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- FRT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FRT Stock Price Chart
What is Federal Realty Investment Trust's stock price today?
-
The Federal Realty Investment Trust share price today is $100.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FRT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
FRT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 51.57 | Buy |
Chaikin Money Flow: | 711534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.07 - 101.55) | Buy |
Bollinger Bands (100): | (99.13 - 102.41) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.91 | Buy |
Relative Strength Index (14 RSI): | 86.77 | Buy |
Chaikin Money Flow: | -1210062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.8 - 205.74) | Buy |
Bollinger Bands (100): | (136.44 - 176.64) | Buy |
FRT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 100.39 | Buy |
20-day SMA: | 100.82 | Buy |
50-day SMA: | 101.28 | Sell |
200-day SMA: | 98.5 | Buy |
8-day EMA: | 100.4 | Buy |
20-day EMA: | 100.58 | Buy |
50-day EMA: | 100.79 | Buy |
200-day EMA: | 99.89 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 209.44 | Buy |
20-day SMA: | 176.25 | Buy |
50-day SMA: | 159.62 | Buy |
200-day SMA: | 165.96 | Buy |
8-day EMA: | 218.01 | Buy |
20-day EMA: | 188.75 | Buy |
50-day EMA: | 168.9 | Buy |
200-day EMA: | 168.09 | Buy |
Federal Realty Investment Trust Earnings Growth & FRT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.07 per share, an increase this year of $0.17 per share, and an increase next year of $0.39 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Federal Realty Investment Trust Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |